Founded in 2015, Harvey Esquire is a Los Angeles-based law firm providing specialized legal services for investment professionals in the emerging fund and venture capital space.
Our team brings decades of combined experience in venture capital law, offering unparalleled expertise to clients worldwide.
Our practice is dedicated to serving venture capital allocators who invest in emerging funds (Fund I - III) and emerging fund managers - including venture capital GPs looking to fundraise. We bring decades of combined experience to guide you through the complexities of the venture capital ecosystem.
We also specialize in early-stage financing transactions, providing comprehensive legal support for pre-seed, seed, and Series A rounds. Our services include manage term sheet negotiations, cap table management, SAFE and convertible note financings, due diligence support, leading NVCA-style equity rounds, and regulatory compliance.
Fund formation means committing to an investment thesis for 10-12+ years backed by a group of investors that believe in your vision. Fund managers have a large task of learning the lingo, connecting the dots and understanding portfolio management. We focus on our core competency: Structuring venture funds and executing on the due diligence process for investors.
We specialize in providing comprehensive legal services for General Partner (GP) and management companies. We understand the intricate legal, operational, and financial responsibilities involved in managing a venture capital firm. Our services are designed to meet compliance standards and manage risks, to allow you to be well-positioned for successful fundraising and capital deployment.
Harvey Esquire provides counsel on M&A transactions involving technology, life sciences, and emerging growth enterprises at the peak stage of development. The firm has experience advising both sellers and purchasers of technology and life sciences, including stock purchase agreements, asset purchase agreements, LLC purchase agreements, and statutory conversions.
Harvey Esquire provides counsel on M&A transactions involving technology, life sciences, and emerging growth enterprises at the peak stage of development. The firm has experience advising both sellers and purchasers of technology and life sciences, including stock purchase agreements, asset purchase agreements, LLC purchase agreements, and statutory conversions.
